Clinical Trial Update: Vericiguat in Decompensated Cardiac Failure: Clinical Insights on Addition to Guidelines Derived Medical Therapy-VERCIG Trial [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial (VERCIG) is evaluating adding vericiguat to guideline-directed medical therapy for patients with decompensated heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Vericiguat (vericiguat)

Snippet

Sponsor: Khawaja Danish Ali | Conditions: Decompensated Heart Failure | Phase 1 | Status: RECRUITING